• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症风险评估的药代动力学模型的精度和灵敏度:小鼠、大鼠和人类中的四氯乙烯

Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans.

作者信息

Bois F Y, Zeise L, Tozer T N

机构信息

Department of Pharmacy, University of California, San Francisco 94143-0446.

出版信息

Toxicol Appl Pharmacol. 1990 Feb;102(2):300-15. doi: 10.1016/0041-008x(90)90029-t.

DOI:10.1016/0041-008x(90)90029-t
PMID:2300971
Abstract

Pharmacokinetic analyses have recently been incorporated in risk assessments, with resultant risks sometimes lower and associated "allowable" exposures higher, than would have been otherwise calculated. Predictions of coupled pharmacokinetic and multistage models, as used for regulatory purposes, are evaluated here for tetrachloroethylene carcinogenicity in mice, rats, and humans. Precision is studied by treating parameters as random variables and determining the range of risk estimates once parameter uncertainties are considered via Monte Carlo simulations. The methods developed in this study are of interest for any similar application. The resultant median risk estimate for humans exposed continuously to 1 ng/liter of tetrachloroethylene in the air is 1.6 per million and 5, 25, 75, and 95 percentiles are 0, 0.04, 2.8, and 6.8 per million. Sensitivity of the pharmacokinetic model predictions to its parameters is assessed by analyzing the results of the Monte Carlo simulations. The kinetic parameters defining the metabolic rate are the most important for the case studied.

摘要

药代动力学分析最近已被纳入风险评估中,其结果是,与原本计算的结果相比,有时风险更低,而相关的“可允许”暴露量更高。本文对用于监管目的的药代动力学和多阶段模型的耦合预测进行了评估,以研究四氯乙烯对小鼠、大鼠和人类的致癌性。通过将参数视为随机变量,并在通过蒙特卡罗模拟考虑参数不确定性后确定风险估计范围,来研究精度。本研究中开发的方法对于任何类似应用都具有重要意义。对于持续暴露于空气中1纳克/升四氯乙烯的人群,所得的中位风险估计值为百万分之1.6,第5、25、75和95百分位数分别为百万分之0、0.04、2.8和6.8。通过分析蒙特卡罗模拟的结果,评估药代动力学模型预测对其参数的敏感性。在所研究的案例中,定义代谢率的动力学参数最为重要。

相似文献

1
Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans.用于癌症风险评估的药代动力学模型的精度和灵敏度:小鼠、大鼠和人类中的四氯乙烯
Toxicol Appl Pharmacol. 1990 Feb;102(2):300-15. doi: 10.1016/0041-008x(90)90029-t.
2
Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).基于生理的药代动力学(PBPK)模型参数的变异性及其在全氯乙烯(PCE)风险评估中对PBPK模型预测的影响。
Toxicol Lett. 1993 May;68(1-2):131-44. doi: 10.1016/0378-4274(93)90126-i.
3
Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output.药代动力学模型输入参数的不确定性评估以及由此产生的输出不确定性评估。
Toxicol Lett. 1989 Dec;49(2-3):371-85. doi: 10.1016/0378-4274(89)90044-1.
4
Uncertainties in health-risk assessment: an integrated case study based on tetrachloroethylene in California groundwater.健康风险评估中的不确定性:基于加利福尼亚州地下水中四氯乙烯的综合案例研究。
Regul Toxicol Pharmacol. 1992 Feb;15(1):86-103. doi: 10.1016/0273-2300(92)90087-p.
5
A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants.一种将基于生理的药代动力学模型与母乳喂养婴儿癌症风险评估相联系的计算机程序。
Comput Methods Programs Biomed. 1995 Feb;46(2):155-63. doi: 10.1016/0169-2607(94)01616-n.
6
Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.基于生理学的药代动力学模型在风险评估中的应用:以全氯乙烯为例。
Crit Rev Toxicol. 2005 Jun;35(5):413-33. doi: 10.1080/10408440590931994.
7
Pharmacokinetics of tetrachloroethylene.四氯乙烯的药代动力学
Toxicol Appl Pharmacol. 1988 Mar 30;93(1):108-17. doi: 10.1016/0041-008x(88)90030-0.
8
Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man.基于生理的药代动力学整合大鼠和人体中三氯乙烯和四氯乙烯动力学数据的潜力。
Br J Ind Med. 1989 Apr;46(4):239-49. doi: 10.1136/oem.46.4.239.
9
Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans.开发和评估一种协调一致的生理基于药代动力学(PBPK)模型,用于研究全氯乙烯在小鼠、大鼠和人体内的毒代动力学。
Toxicol Appl Pharmacol. 2011 Jun 15;253(3):203-34. doi: 10.1016/j.taap.2011.03.020. Epub 2011 Apr 3.
10
Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors.全氯乙烯药代动力学建模中的不确定性。I. 不同作者推导模型的模型结构、参数及低剂量代谢率预测的比较。
Risk Anal. 1990 Sep;10(3):449-58. doi: 10.1111/j.1539-6924.1990.tb00528.x.

引用本文的文献

1
Method "Monte Carlo" in healthcare.医疗保健中的“蒙特卡洛”方法。
World J Methodol. 2024 Sep 20;14(3):93930. doi: 10.5662/wjm.v14.i3.93930.
2
A scalable computational framework for establishing long-term behavior of stochastic reaction networks.用于建立随机反应网络长期行为的可扩展计算框架。
PLoS Comput Biol. 2014 Jun 26;10(6):e1003669. doi: 10.1371/journal.pcbi.1003669. eCollection 2014 Jun.
3
Human health effects of tetrachloroethylene: key findings and scientific issues.四氯乙烯对人体健康的影响:主要发现与科学问题
Environ Health Perspect. 2014 Apr;122(4):325-34. doi: 10.1289/ehp.1307359. Epub 2014 Feb 14.
4
Addressing human variability in next-generation human health risk assessments of environmental chemicals.解决环境化学物下一代人体健康风险评估中的人类变异性问题。
Environ Health Perspect. 2013 Jan;121(1):23-31. doi: 10.1289/ehp.1205687. Epub 2012 Oct 19.
5
Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS.使用WinBUGS中具有信息先验分布的贝叶斯群体生理药代动力学模型,从临床前到I期的地西泮药代动力学。
J Pharmacokinet Pharmacodyn. 2006 Oct;33(5):571-94. doi: 10.1007/s10928-006-9023-3. Epub 2006 Jun 29.
6
Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.开发一个基于生理学的全身模型以表征苯二氮䓬类药物的药代动力学。1:大鼠组织-血浆分配比的估算
J Pharmacokinet Pharmacodyn. 2004 Aug;31(4):269-98. doi: 10.1023/b:jopa.0000042737.14033.c6.
7
Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepam.药代动力学模型的模糊模拟:地西泮全身生理药代动力学模型的案例研究
J Pharmacokinet Pharmacodyn. 2004 Jun;31(3):185-213. doi: 10.1023/b:jopa.0000039564.35602.78.
8
Incorporating children's toxicokinetics into a risk framework.将儿童毒代动力学纳入风险框架。
Environ Health Perspect. 2004 Feb;112(2):272-83. doi: 10.1289/ehp.6013.
9
Whole body pharmacokinetic models.全身药代动力学模型。
Clin Pharmacokinet. 2003;42(10):883-908. doi: 10.2165/00003088-200342100-00002.
10
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.开发一种基于生理学的三氯乙烯及其代谢物药代动力学模型,用于风险评估。
Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):283-305. doi: 10.1289/ehp.00108s2283.